Skip to main content
. 2018 Feb 19;10(2):229–240. doi: 10.18632/aging.101384

Figure 11.

Figure 11

Overall Work-Flow: Identifying mitochondrial inhibitors to target CSC propagation. Here, we selected TPP-related compounds as the starting point for screening, because this ensures that all the compounds tested are targeted to mitochondria. Remarkably, we show that this strategy yields mitochondrial inhibitors of CSCs that are non-toxic in normal human fibroblasts, thereby effectively limiting drug toxicity.